Literature DB >> 20188151

(R)-roscovitine prolongs the mean open time of unitary N-type calcium channel currents.

N R DeStefino1, A A Pilato, M Dittrich, S V Cherry, S Cho, J R Stiles, S D Meriney.   

Abstract

(R)-roscovitine (Ros) is a cyclin-dependent kinase inhibitor that also has been shown to have direct agonist and antagonist actions on Ca(v)2.1 (P/Q-type) and Ca(v) 2.2 (N-type) families of voltage-gated calcium channels. These kinase-independent effects represent a novel opportunity to advance our understanding of calcium channel function and calcium-triggered neurotransmitter release. Furthermore, such actions on calcium channels may direct the development of Ros derivatives as new therapeutic agents. We used patch clamp recordings to characterize mechanisms that underlie the agonist effects of Ros on unitary N-type calcium channel gating. We found that N-type channels normally gate with either a short or long mean open time, that Ros significantly prolonged the mean open time of the long gating component and increased the probability of observing channels that gated with a long open time, but had no effect on single channel conductance. Using Monte Carlo simulations of a single channel kinetic model and Ros interactions, we were able to reproduce our experimental results and investigate the model's microscopic dynamics. In particular, our simulations predicted that the longer open times generated by Ros were due to the appearance of a long open state combined with an increased amount of time spent in transitions between open states. Our results suggest a mechanism for agonist effects of Ros at the level of single channels, and provide a mechanistic explanation for previously reported agonist effects on whole cell calcium currents. Copyright 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20188151      PMCID: PMC2854255          DOI: 10.1016/j.neuroscience.2010.02.041

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  50 in total

1.  G-protein inhibition of N- and P/Q-type calcium channels: distinctive elementary mechanisms and their functional impact.

Authors:  H M Colecraft; D L Brody; D T Yue
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

2.  Ca2+ from one or two channels controls fusion of a single vesicle at the frog neuromuscular junction.

Authors:  Vahid Shahrezaei; Alex Cao; Kerry R Delaney
Journal:  J Neurosci       Date:  2006-12-20       Impact factor: 6.167

3.  Reversible uncoupling of inactivation in N-type calcium channels.

Authors:  M R Plummer; P Hess
Journal:  Nature       Date:  1991-06-20       Impact factor: 49.962

4.  Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.

Authors:  W Zheng; D Rampe; D J Triggle
Journal:  Mol Pharmacol       Date:  1991-11       Impact factor: 4.436

5.  Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine.

Authors:  Zafir Buraei; Mircea Anghelescu; Keith S Elmslie
Journal:  Biophys J       Date:  2005-06-10       Impact factor: 4.033

6.  Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons.

Authors:  Zhen Yan; Ping Chi; James A Bibb; Timothy A Ryan; Paul Greengard
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

7.  Roscovitine differentially affects CaV2 and Kv channels by binding to the open state.

Authors:  Zafir Buraei; Geoffrey Schofield; Keith S Elmslie
Journal:  Neuropharmacology       Date:  2006-11-27       Impact factor: 5.250

8.  Spatial Distribution of Calcium Entry Evoked by Single Action Potentials within the Presynaptic Active Zone.

Authors:  Elliot S Wachman; Robert E Poage; Joel R Stiles; Daniel L Farkas; Stephen D Meriney
Journal:  J Neurosci       Date:  2004-03-24       Impact factor: 6.167

9.  Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells.

Authors:  S Kokubun; H Reuter
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  Calcium channel selectivity for divalent and monovalent cations. Voltage and concentration dependence of single channel current in ventricular heart cells.

Authors:  P Hess; J B Lansman; R W Tsien
Journal:  J Gen Physiol       Date:  1986-09       Impact factor: 4.086

View more
  11 in total

Review 1.  Regulation by L-type calcium channels of endocytosis: an overview.

Authors:  Juliana M Rosa; Carmen Nanclares; Angela Orozco; Inés Colmena; Ricardo de Pascual; Antonio G García; Luis Gandía
Journal:  J Mol Neurosci       Date:  2012-05-12       Impact factor: 3.444

2.  An excess-calcium-binding-site model predicts neurotransmitter release at the neuromuscular junction.

Authors:  Markus Dittrich; John M Pattillo; J Darwin King; Soyoun Cho; Joel R Stiles; Stephen D Meriney
Journal:  Biophys J       Date:  2013-06-18       Impact factor: 4.033

3.  Synthesis and biological evaluation of a selective N- and p/q-type calcium channel agonist.

Authors:  Mary Liang; Tyler B Tarr; Karla Bravo-Altamirano; Guillermo Valdomir; Gabriel Rensch; Lauren Swanson; Nicholas R DeStefino; Cara M Mazzarisi; Rachel A Olszewski; Gabriela Mustata Wilson; Stephen D Meriney; Peter Wipf
Journal:  ACS Med Chem Lett       Date:  2012-10-01       Impact factor: 4.345

Review 4.  Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leads.

Authors:  Stephen D Meriney; Tyler B Tarr; Kristine S Ojala; Man Wu; Yizhi Li; David Lacomis; Adolfo Garcia-Ocaña; Mary Liang; Guillermo Valdomir; Peter Wipf
Journal:  Ann N Y Acad Sci       Date:  2017-11-10       Impact factor: 5.691

5.  Domain III regulates N-type (CaV2.2) calcium channel closing kinetics.

Authors:  Viktor Yarotskyy; Guofeng Gao; Blaise Z Peterson; Keith S Elmslie
Journal:  J Neurophysiol       Date:  2011-12-28       Impact factor: 2.714

6.  New Cav2 calcium channel gating modifiers with agonist activity and therapeutic potential to treat neuromuscular disease.

Authors:  Man Wu; Hayley V White; Blake A Boehm; Christopher J Meriney; Kaylan Kerrigan; Michael Frasso; Mary Liang; Erika M Gotway; Madeleine R Wilcox; Jon W Johnson; Peter Wipf; Stephen D Meriney
Journal:  Neuropharmacology       Date:  2017-12-12       Impact factor: 5.250

Review 7.  Stabilizers of neuronal and mitochondrial calcium cycling as a strategy for developing a medicine for Alzheimer's disease.

Authors:  José-Carlos Fernández-Morales; Juan-Alberto Arranz-Tagarro; Enrique Calvo-Gallardo; Marcos Maroto; Juan-Fernando Padín; Antonio G García
Journal:  ACS Chem Neurosci       Date:  2012-08-29       Impact factor: 4.418

Review 8.  Synaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome.

Authors:  Tyler B Tarr; Peter Wipf; Stephen D Meriney
Journal:  Mol Neurobiol       Date:  2014-09-09       Impact factor: 5.590

9.  Opposite Roles in Short-Term Plasticity for N-Type and P/Q-Type Voltage-Dependent Calcium Channels in GABAergic Neuronal Connections in the Rat Cerebral Cortex.

Authors:  Kiyofumi Yamamoto; Masayuki Kobayashi
Journal:  J Neurosci       Date:  2018-09-24       Impact factor: 6.167

10.  Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndrome.

Authors:  Tyler B Tarr; Waqas Malick; Mary Liang; Guillermo Valdomir; Michael Frasso; David Lacomis; Stephen W Reddel; Adolfo Garcia-Ocano; Peter Wipf; Stephen D Meriney
Journal:  J Neurosci       Date:  2013-06-19       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.